MapLight Therapeutics, Inc. MPLT 深 滬
等待開盤 12-06 09:30:00 美东时间
18.49
+0.150
+0.82%
華盛通- 最 高19.2462
- 今 開18.10
- 成交量 36.56万股
- 最 低 17.82
- 昨 收 18.34
- 總市值 7.66亿
- 52周最高 20.8558
- 市盈率 靜 --
- 換手率 0.88%
- 52周最低 12.24
- 委 比 -60.00%
- 總股本 4142.89万
- 歷史最高 20.8558
- 量 比 1.00
- 振 幅 7.78%
- 歷史最低 12.24
- 每 手 1
- 風險率 1.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MapLight Therapeutics Q3 EPS $(37.18) Misses $(1.55) Estimate
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(37.18) per share which missed the analyst consensus estimate of $(1.55) by 2291 percent. This is a 48.25 percent decrease over losses of $(25.08) per
12-04 21:06
美股牛股 | 机器人概念股集体爆发！iRobot涨超73%，Richtech Robotics涨超18%；医药股Capricor暴涨超371%
机器人概念股集体爆发！iRobot涨超73%，Richtech Robotics涨超18%，特朗普新政拟All in 机器人；医药股Capricor暴涨超371%，关键实验获重大突破>>
12-04 15:42
Marvell Posts Strong Q3 Earnings, Joins American Eagle, Microchip Technology, Box And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones gaining around 100 points on Wednesd...
12-03 23:16
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
11-24 11:23
Morgan Stanley Initiates Coverage On MapLight Therapeutics with Overweight Rating, Announces Price Target of $34
Morgan Stanley analyst Sean Laaman initiates coverage on MapLight Therapeutics (NASDAQ:MPLT) with a Overweight rating and announces Price Target of $34.
11-21 20:19
一周IPO | 滴普科技上市三日股价涨320%；明略科技、赛力斯下周上市；小马智行、旺山旺水等5家招股中
滴普科技上市三日股价涨320%；明略科技、赛力斯下周上市；小马智行、旺山旺水等5家招股中；美股低空经济最大IPO即将来袭！>>
11-01 13:56
MapLight Therapeutics Closes Successful IPO and Private Placement
MapLight Therapeutics, Inc. ( ($MPLT) ) has issued an announcement. MapLight Th...
10-29 21:28
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
MapLight Therapeutics completed its initial public offering, raising $296.3 million through the sale of 16.96 million shares at $17 each, including underwriters' option exercise. The shares, trading under "MPLT" on the Nasdaq, began on October 27. Morgan Stanley, Jefferies, Leerink Partners, and Stifel led the offering. MapLight focuses on treatments for CNS disorders like schizophrenia and Alzheimer's disease psychosis, with its lead candidate i...
10-29 13:06
首日收盘 | MapLight Therapeutics, Inc.今日挂牌，尾盘收跌8.67%
Apex Technology Acquisition Corp. Units Cons of 1 Sh -A- + 0.5 Wt 11.06.26涨0.60%，最新市值3.52亿美元；MapLight Therapeutics, Inc.跌8.67%，最新市值6.94亿美元；
10-29 06:00
新股首日|MapLight Therapeutics, Inc.现涨7.88%，最新总市值7.60亿美元
MapLight Therapeutics, Inc.涨7.88%，最新市值7.60亿美元；
10-28 19:36
